KALEIDO
Live / Registered — Registered (as of 17 Dec 2019)
What this means for you
Registered since 17 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86783357
- Registration number
- 5938245
- Mark type
- Stylized text
- Filed
- 09 Oct 2015
- Published for opposition
- 28 Aug 2018
- Registered
- 17 Dec 2019
- Attorney of record
- Christina Licursi
Goods and services
- Class 005 — Pharmaceuticals: preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis; therapeutic pharmaceuticals for medical use, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis
Owner
- KALEIDO BIOSCIENCES, INC., Lexington, MA, US
- KALEIDO BIOSCIENCES, INC., Lexington, MA, US
- KALEIDO BIOSCIENCES, INC., BEDFORD, MA, US
- VL32, Inc., Cambridge, MA, US
Prosecution history
- 17 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 13 Nov 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Nov 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Nov 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Oct 2019 — USE AMENDMENT FILED
- 02 Nov 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Oct 2019 — TEAS STATEMENT OF USE RECEIVED
- 25 Apr 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Apr 2019 — SOU EXTENSION 1 GRANTED
- 23 Apr 2019 — SOU EXTENSION 1 FILED
- 23 Apr 2019 — SOU TEAS EXTENSION RECEIVED
- 02 Jan 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Jan 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Oct 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT